YDES
YD Bio LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$338.50M
P/E Ratio
—
EPS
$-0.02
Beta
0.22
52W High
$25.00
52W Low
$4.80
50-Day MA
$6.85
200-Day MA
$11.58
Dividend Yield
—
Profit Margin
-276.60%
Forward P/E
—
PEG Ratio
—
About YD Bio Ltd
Breeze Holdings Acquisition Corp. The company is headquartered in Taipei, Taiwan.
Fundamentals
| Revenue (TTM) | 510,360 |
| Gross Profit (TTM) | 155,360 |
| EBITDA | $-1.36M |
| Operating Margin | -444.60% |
| Return on Equity | -42.70% |
| Return on Assets | -25.40% |
| Revenue/Share (TTM) | $0.47 |
| Book Value | $4.57 |
| Price-to-Book | 66.53 |
| Price-to-Sales (TTM) | 663.26 |
| EV/Revenue | 662.37 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 95.60% |
| Shares Outstanding | $70.52M |
| Float | 319,870 |
| % Insiders | 81.01% |
| % Institutions | 0.47% |
Historical Volatility
HV 10-Day
45.43%
HV 20-Day
87.29%
HV 30-Day
115.86%
HV 60-Day
99.24%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/2/2026